0001140361-12-032877.txt : 20120711 0001140361-12-032877.hdr.sgml : 20120711 20120711123336 ACCESSION NUMBER: 0001140361-12-032877 CONFORMED SUBMISSION TYPE: D PUBLIC DOCUMENT COUNT: 1 ITEM INFORMATION: Rule 506 FILED AS OF DATE: 20120711 DATE AS OF CHANGE: 20120711 EFFECTIVENESS DATE: 20120711 FILER: COMPANY DATA: COMPANY CONFORMED NAME: INTEGRATED BIOPHARMA INC CENTRAL INDEX KEY: 0001016504 STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834] IRS NUMBER: 222407475 STATE OF INCORPORATION: DE FISCAL YEAR END: 0630 FILING VALUES: FORM TYPE: D SEC ACT: 1933 Act SEC FILE NUMBER: 021-181032 FILM NUMBER: 12957415 BUSINESS ADDRESS: STREET 1: 201 ROUTE 22 CITY: HILLSIDE STATE: NJ ZIP: 07205 BUSINESS PHONE: 9739260816 MAIL ADDRESS: STREET 1: 201 ROUTE 22 CITY: HILLSIDE STATE: NJ ZIP: 07205 FORMER COMPANY: FORMER CONFORMED NAME: INTEGRATED HEALTH TECHNOLOGIES INC DATE OF NAME CHANGE: 20020912 FORMER COMPANY: FORMER CONFORMED NAME: CHEM INTERNATIONAL INC DATE OF NAME CHANGE: 19960716 D 1 primary_doc.xml X0706 D LIVE 0001016504 INTEGRATED BIOPHARMA INC 225 Long Avenue HILLSIDE NJ NEW JERSEY 07205 8002925234 DELAWARE None INTEGRATED HEALTH TECHNOLOGIES INC CHEM INTERNATIONAL INC Corporation true E. Gerald Kay 225 Long Avenue Hillside NJ NEW JERSEY 07205 Executive Officer Director Christina Kay 225 Long Avenue Hillside NJ NEW JERSEY 07205 Executive Officer Director Riva Sheppard 225 Long Avenue Hillside NJ NEW JERSEY 07205 Executive Officer Director Dina L. Masi 225 Long Avenue Hillside NJ NEW JERSEY 07205 Executive Officer Robert Canarick 225 Long Avenue Hillside NJ NEW JERSEY 07205 Director William Milmoe 225 Long Avenue Hillside NJ NEW JERSEY 07205 Director Carl De Santis 225 Long Avenue Hillside NJ NEW JERSEY 07205 Director Other Health Care $25,000,001 - $100,000,000 06 false 2012-06-27 false true true true Secured convertible promissory note and the underlying shares of common stock issuable upon conversion thereof. false 0 5350000 5350000 0 Secured convertible note, in the original principal amount of $5,350,000, convertible into common stock of the Issuer at a conversion price of $0.65, subject to customary adjustments. false 1 0 0 0 false INTEGRATED BIOPHARMA INC /s/ Dina L. Masi Diina L. Masi Chief Financial Officer 2012-07-11